INNOventure

What INNOventure does

INNOventure ASI Sp. z o.o. is a Kraków-based, privately held seed-stage venture capital fund that invests in early-stage technology companies emerging from Polish and broader European R&D. The firm targets proof-of-principle and proof-of-concept stage projects led by scientists, inventors, and entrepreneurs, deploying typically up to PLN 1 million per company (up to PLN 3 million in exceptional cases) in exchange for minority equity, with a stated 3-7 year investment horizon. The fund is structured as a joint venture between Krakowski Park Technologiczny (Krakow Technology Park) and SATUS Venture, and was established to implement the NCBiR-coordinated BRIdge Alfa program, which provides PLN 30 million of project financing co-funded at 80% by the European Regional Development Fund under the Intelligent Development Operational Program.

The portfolio spans roughly twenty disclosed companies across MedTech (Cardiomatics, Neuromedical, Laven, Saventic Health, SiDLY), IoT (Phonemic), AI (DigitalFirst.AI, Sky Engine, Minte.ai), Biotech (Amorphis Pharma Development, PolTREG), IT (RevDeBug, Sky Engine, Drukuje.to, Exon, WIDMO Spectral Technologies), and InsurTech (Minte.ai), with several realized exits including PolTREG, SiDLY, SDS Optic, Synerise, Optimo Light, Open App, and ARA HUB. INNOventure's revenue mechanics follow a standard seed-fund model: management fees on committed capital, supplemented by carried interest on exits, and the fund also participates in co-investments with other VC funds and business angels — most notably co-leading Mindpeak GmbH's $15.3 million Series A (September 2024) alongside ZEISS Ventures.

The management team is led by two Managing Directors — Marcin Bielówka (fund management, partner relationships) and Marcin Molo (portfolio construction and transaction structuring) — supported by four Investment Managers (Leszek Skowron, Krzysztof Homziuk, Karol Kaczmarczyk, Krystian Trela) and an Operations Manager (Aldona Chwalik-Raczyńska). The partners previously co-created and managed the KPT Seed Fund. Go-to-market is direct and relationship-driven: deal sourcing flows through KPT and SATUS ecosystems, the Unicorn Hub partnership covering Eastern Poland, and content marketing via the BRIdge ALFAbet educational glossary. The firm is not listed, has no public financials, and operates from a single Kraków office at Podole 60.

Name

INNOventure

Legal name

INNOventure ASI Sp. z o.o.

Website

https://innoventure.vc

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

INNOventure is a Kraków-based seed-stage venture capital fund that invests up to PLN 3 million per deal in early-stage technology companies commercializing R&D. It targets scientists, inventors, and entrepreneurs across MedTech, IoT, AI, Biotech, and IT, and is jointly operated under the EU-backed BRIdge Alfa program.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Investment Pools and Funds (5259), Other Financial Vehicles (52599)

SIC

Investment Advice (6282), Services-Management Consulting Services (8742)

akta.pro primary industry

Late-Stage Venture Capital (Series C+) (FSANAAAC)

Keywords

• Venture capital fund
• Seed stage investing
• Technology commercialization
• Early stage startups
• R&D commercialization

Headquarters

HQ city

Kraków

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Investment Returns: Returns are generated through exit transactions - selling shares to trade buyers or financial investors in a way that is optimal for the further development of the enterprise. The fund operates with a 3-7 year investment time horizon.
2. Portfolio Company Growth: The fund builds value in companies based on R&D project results, then exits through sale of shares to subsequent investors or trade buyers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

INNOventure is a seed-stage venture capital fund that invests minority equity stakes (typically up to PLN 1 million, up to PLN 3 million in exceptional cases) in early-stage technology companies at proof-of-principle and proof-of-concept stages. The fund targets innovative scientists, engineers, and entrepreneurs commercializing R&D projects in MedTech, IoT, AI, IT, InsurTech, and Biotech, providing capital alongside mentorship, business-model support, and access to co-investor networks under a 3–7 year investment horizon.

Differentiator

Problem solved

Functional benefit

Products and services

• INNOventure Seed Investment Fund

Quantifiable outcome

• Projects supported by INNOventure team have raised hundreds of millions of euros from investments, grants, and IPOs
• +1 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Krakowski Park Technologiczny (Krakow Technology Park)coreStrategic or Co-development PartnerJoint venture partner in creating INNOventure as part of BRIdge Alfa program implementation. KPT provides the ecosystem foundation including non-financial support opportunities for portfolio companies in biotechnology and MedTech sectors.
• SATUS VenturecoreStrategic or Co-development PartnerGroup of venture capital funds and private investors that co-created INNOventure as a joint venture to support innovative startups.
• KPT Seed FundminorStrategic or Co-development PartnerINNOventure staff co-created and managed KPT Seed Fund, one of the most acclaimed funds supporting innovative startups in Poland. This represents a successful prior collaboration that informs current operations.
• Unicorn Hub (Startup Platform)minorStrategic or Co-development PartnerINNOventure is a partner in the Unicorn Hub project supporting development of innovative startups from Eastern Poland through comprehensive incubation program. Project value PLN 18,197,893.31, co-financed by EU under European Regional Development Fund.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• KPT (Krakowski Park Technologiczny) Seed Fund: KPT Seed Fund is the predecessor vehicle co-created by INNOventure's Managing Directors and operates in the same Kraków ecosystem with a near-identical seed-stage, science-commercialization mandate. Direct precedent for fund model and overlap on portfolio sourcing relationships.
• SATUS Venture: Polish VC group and co-creator of INNOventure alongside KPT. Invests in early-stage technology companies with a similar science-and-engineering focus, making it a structural peer with overlapping deal flow and co-investment activity.
• Credo Ventures: Czech-based seed and Series A venture fund investing across Central Europe in technology and science-driven startups. Comparable geography, stage, and check-size profile, with similar MedTech/deep-tech orientation.
• Unbundl (formerly Unia Europejska / Unicorn Hub): Polish incubator/seed program where INNOventure is a partner; both support Eastern Poland deep-tech startups via EU co-financing. Overlapping deal source pool, parallel fund-of-funds structure for early commercialization.

Broad incumbents

• Speedinvest: One of Europe's largest early-stage funds with a Sector-focused model (Deep Tech, Health, Industrial Tech) and active presence in CEE. Larger AUM and broader geographic reach, but directly comparable at the seed-stage deep-tech intersection where INNOventure operates.
• btov Partners: European seed and early-stage fund with a dedicated Digital Tech and Industrial Tech practice investing alongside university spinouts across DACH and CEE. Larger fund size but analogous stage, deep-tech thesis, and science-commercialization angle.
• High-Tech Gründerfonds (HTGF): Germany's flagship seed-stage public-private deep-tech fund. Closest European analogue to the BRIdge Alfa-funded INNOventure model: government-backed, technology-transfer oriented, science-commercing startups at proof-of-concept stage.
• Earlybird Venture Capital: Berlin-based pan-European early-stage fund with dedicated deep-tech and health-tech verticals. Comparable on stage and science-backed thesis, with much larger AUM and broader LP base.

Emerging players

• APEX Ventures: Vienna-based early-stage VC specializing in deep-tech and science-driven spinouts from European research institutions. Similar niche focus and ticket size, with comparable relationship to EU/public funding programs.

Regional players

• JR Holding / Joint Polish Investment Fund (Start In Poland): Polish state-aligned capital vehicles providing seed and pre-seed funding for innovative Polish startups, including deep tech and university spinouts. Operates in the same geographic and policy environment with comparable mandate around EU-funded commercialization.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/INNOventure.vc
• LinkedInlinkedin.com/company/innoventure-sp-z-o-o-

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments21 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INNOventure